Article Details

BCL2 Inhibitor in Combination With Anti-CD20 mAb for CLL

Retrieved on: 2021-08-02 15:06:59

Tags for this article:

Click the tags to see associated articles and topics

BCL2 Inhibitor in Combination With Anti-CD20 mAb for CLL. View article details on hiswai:

Excerpt

Kirollos S. Hanna, PharmD, BCPS, BCOP, discusses data on a BCL2 inhibitor in combination with anti-CD20 monoclonal antibodies in the treatment ...

Article found on: www.pharmacytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up